Location History:
- Village-Nuef, FR (2006)
- Saint-Louis, FR (2003 - 2010)
- Village-Neuf, FR (2006 - 2019)
Company Filing History:
14 out of 31 
10 out of 3,923 
3 out of 21 Years Active: 2003-2025
Title: Pierre Ducray: A Prolific Inventor in the Field of Therapeutic Agents
Introduction: Pierre Ducray, hailing from Village-Neuf, France, is a renowned inventor with an impressive portfolio of 27 patents. His innovative contributions have significantly impacted the field of therapeutic agents, particularly in areas such as organ transplants, autoimmune disorders, and chronic diseases. In this article, we will delve into Ducray's latest patents, career highlights, noteworthy collaborations, and acknowledge his valuable contributions to the scientific community.
Latest Patents: One of Pierre Ducray's recent patents encompasses the development of heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors. This novel compound, represented by formula (I), has demonstrated potential therapeutic benefits in treating various ailments, including organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, cancer, asthma, and more. The versatility of these compounds has also showcased promising results for conditions like Alzheimer's disease, osteoarthritis, and ulcerative colitis, amongst others.
Career Highlights: Pierre Ducray's prolific career has seen him make significant contributions to the field of medicinal chemistry. His expertise and dedication have led him to secure a remarkable 27 patents, solidifying his position as a leading innovator in the industry. Ducray's patent portfolio showcases his commitment to developing effective therapeutic agents that address a wide range of medical conditions, earning him recognition for his invaluable contributions to healthcare and patient well-being.
Collaborations: Pierre Ducray has had the privilege of collaborating with esteemed professionals in his field. Among his notable coworker mentions are Thomas Goebel and Jacques Bouvier. Their combined expertise and collaboration have likely resulted in innovative breakthroughs and the successful development of novel compounds. These collaborations emphasize Ducray's commitment to teamwork and knowledge sharing, enabling him to maximize his impact in the field of therapeutic agents.
Conclusion: Pierre Ducray's unwavering passion for creating innovative therapeutic solutions has culminated in an impressive patent portfolio of 27 patents. From the recent development of heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors to his contributions in addressing a wide range of medical conditions, Ducray's inventions have undoubtedly left a lasting impact on the field. As an inventor, he continues to push boundaries and contribute to advancements in therapeutic agents, solidifying his position as a prominent figure in the scientific community.
Disclaimer: The information provided in this article is based on publicly available data and should not be considered as official endorsements or affiliations of idiyas.com.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.